Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease-Reference-Cited by-同舟云学术

Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease

Published:2014 Issue:6 Volume:55 Page:482-483
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Imamura Teruhiko¹

Affiliation:

1. Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, University of Tokyo

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/55/6/55_14-217/_pdf

Reference13 articles.

1. 1. Kinugawa K, Sato N, Inomata T, Shimakawa T, Iwatake N, Mizuguchi K. Efficacy and safety of tolvaptan in heart failure patients with volume overload. Circ J 2014; 78: 844-52.

2. 2. Kinugawa K, Imamura T, Komuro I. Experience of a vasopressin receptor antagonist, tolvaptan, under the unique indication in Japanese heart failure patients. Clin Pharmacol Ther 2013; 94: 449-51.

3. 3. Imamura T, Kinugawa K, Shiga T, et al. Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients--association between non-responders and chronic kidney disease. Circ J 2013; 77: 397-404.

4. 4. Sato E, Nakamura T, Amaha M, et al. Effect of tolvaptan on patients with chronic kidney disease due to diabetic nephropathy with heart failure. Int Heart J (in press)

5. 5. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 1993; 361: 549-52.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure;Circulation Journal;2022-05-25

2. Long-Term Tolvaptan Treatment in Refractory Heart Failure;Circulation Reports;2019-10-10

3. Does Tolvaptan Have Any Therapeutic Roles in Patients With Left Ventricular Assist Device?;ASAIO Journal;2019-09

4. Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome;Internal Medicine;2017

5. Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials;Journal of Cardiovascular Pharmacology;2016-09